Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEO-FLOT: Perioperative Chemotherapy for Gastric Cancer
NCT01160419Phase 2Unknown
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Dec 2009
- Primary completion
- May 2011
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin, folinic acid, fluorouracil in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Ludwig Maximilian University of Munich. Status: unknown.
02
Drugs
docetaxeloxaliplatinfolinic acidfluorouracil
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01160419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01160419.